Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001753926-24-001974
Filing Date
2024-11-20
Accepted
2024-11-20 16:03:23
Documents
1
Period of Report
2024-09-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3067
  Complete submission text file 0001753926-24-001974.txt   4661
Mailing Address C/O SLOAN CAPITAL COMPANIES 4734 25TH AVENUE NE SEATTLE WA 98105
Business Address
SLOAN STUART M (Reporting) CIK: 0001215280 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40877 | Film No.: 241480300

Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001870404 (see all company filings)

EIN.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)